Introduction
The age of mechanical support for failing organs is part of our routine medical care, and technology has allowed us to provide support for kidney, lung, heart, and even liver function. While this technology is still imperfect, progress is being made. This is highlighted in the realm of extracorporeal membrane oxygenation (ECMO). Over the last year, we have worked diligently to establish the adult ECMO program at Jackson Health System (JHS) in conjunction with the Miami Transplant Institute (MTI) and the University of Miami. This collaboration of institutions is known as the Miami Atlantic Southeast CArdiopulmonary REscue Network (MAS-CARE Network). Here, we describe some of the key components that established the MAS-CARE network as a robust, tertiary referral center.
Adult ECMO program
ECMO is a multidisciplinary method of therapy with indications ranging from refractory respiratory failure requiring venovenous (VV) ECMO support to end-stage heart failure necessitating venoarterial (VA) ECMO. No matter which modality is needed, ECMO is a labor-and resourceintensive process. A hub-and-spoke model, with a tertiary ECMO center as the hub, has been described for heart failure patients requiring mechanical support. Early transfer to the nearest center able to provide mechanical support and an exit strategy is key. Destination therapy for heart failure includes ventricular assist devices (VADs) or heart transplant, and it is imperative for patients to be treated in centers capable of providing these therapies. For respiratory failure, it has been demonstrated that transfer to an institution with ECMO capability and expertise improves patient survival. 1 Therefore, the MAS-CARE adult ECMO program was designed to provide the patients of South Florida with the full complement of mechanical support for respiratory and/or cardiac failure.
ECMO is a rescue therapy initiated on the sickest of patients and requires the skillset of multiple teams and careful coordination between them. We have reconciled the many moving parts of this therapy by establishing clearly defined roles and responsibilities. The intensive care team is responsible for all the day-to-day care of the patient, including ventilator management. The cardiothoracic (CT) surgeons from MTI are responsible for cannulation, the ECMO device, cannula maintenance, weaning trials, and decannulation.
Our adult ECMO program is composed of a large team of perfusionists, as well as the physicians and staff from various specialties including CT surgery and each of the critical care specialties: surgical, pulmonary, and anesthesia. Other medical specialists from specialties such as cardiology and infectious disease, as well as nursing, respiratory therapy, and pharmacy, are also involved. Within each intensive care unit (ICU), there is a physician liaison. Currently, we have participation from the Coronary Care Unit, as well as the Medical, Surgical, and Trauma ICUs. As the program has evolved, we have formalized many of our quality initiatives. We now have a dedicated monthly ECMO Quality and Operations Council review meeting, as well as a separate meeting for Morbidity and Mortality. These meetings are always multidisciplinary in nature and include representatives from ancillary departments as well as physician representatives from all the ICUs. At these meetings, we discuss the most current outcomes related to our ECMO program, identify opportunities for improvement, and implement changes accordingly.
A palliative care consultation is performed simultaneously with cannulation for every patient who undergoes ECMO therapy at our institution. The decision to involve the palliative service early after ECMO was a natural progression of the team's service, as they are active members of our transplant team. If a patient's care reaches futility and there is no viable "exit strategy," that is, VAD or transplant option, ECMO therapy is deemed futile care. The difficult decision to withdraw support is made on a case-by-case basis with family, the multidisciplinary team, and the assistance of the palliative care team.
VV ECMO
A unique learning curve involved with initiating and subsequently maintaining an adult ECMO program is the need for a common language between the various medical specialties. Standardizing language and establishing protocols has been a main focus during the development of our adult ECMO program.
Due to large heterogeneity in management, one of our early initiatives was the establishment of a standardized management and weaning protocol for VV ECMO ( Figure 1 ). 2 This protocol provides a common language for the various ICU physicians to discuss the management of the patient with the CT surgeons, perfusionists, respiratory therapists, and other specialists who are helping to manage these complex patients.
Integral to the VV ECMO management and weaning protocol is the use of our lung protective strategy. The particular strategy employed at our institutions is called the ECMO for Lung PROtective Ventilation (EMPROVE) protocol. EMPROVE is a set of guidelines for ventilator management designed to minimize ventilator-induced lung injury (VILI; Table 1 ). This protocol was developed from the collective experience of our group and the best clinical data available for lung protection. 2 Of course, day-to-day care is still performed with hemoglobin checks, transfusions to keep hematocrit above 30, and close surveillance for infection. Our staff is educated about cannula care as well as modifications in pulmonary hygiene protocols since frequent suctioning is contraindicated in patients placed on the EMPROVE protocol. A daily checklist has also been developed to facilitate communication between support staff and the various medical teams. This checklist includes the phases of management of VV ECMO, further establishing a common language between practitioners and facilitating daily goals of care (Table 2) .
Despite technological advances, ECMO remains a labor-intensive and resource-intensive therapy. Therefore, as enthusiasm for our ECMO program has grown, the value of solidifying the indications for the use of this therapy at our institution was quickly realized. Table 3 outlines the indications for ECMO at our institution.
VA ECMO
The patients requiring VA ECMO are arguably the most acutely ill patients in any hospital. Indications for VA ECMO at our institution are the same as those described by Ghodsizad et al. 3 These patients are often in multisystem organ failure and require high doses of vasopressor and/or inotropic support. This patient population remains plagued by high mortality rates and severe co-morbidities related to their overall disease process. The ECMO team works closely with the heart failure team at our institution to provide a multidisciplinary approach to these patients.
A recent meta-analysis demonstrated that critical limb ischemia and limb loss affect 8%-12% of VA ECMO patients. 4 However, limb ischemia has been widely underreported, and other series have demonstrated rates as high as 18%-20%. 5, 6 Prevention of limb loss has become a focus of research for our team, and we are working to develop innovative ways to permit distal perfusion.
Extracorporeal cardiopulmonary resuscitation
Early in the development of our adult ECMO program, we created an "ECMO Hotline" which can be dialed from anywhere within South Florida and will connect you with an ECMO team member. It has been utilized on a number of occasions and has brought our CT surgeons to the bedside of many patients undergoing cardiopulmonary resuscitation. Despite the newness of our adult program, our extracorporeal cardiopulmonary resuscitation (ECPR) survival rate is comparable to the international average described by Extracorporeal Life Support Organization (ELSO). 7 Currently, at our institution, ECPR is defined as being performed on any patient who has evidence of refractory shock despite maximal vasopressor/inotropic support or any patient who is and has undergone mechanical resuscitation within 24 h of cannulation. More important than the indications for ECPR are the contraindications, as there is still no clear evidence defining who will actually benefit from ECMO during resuscitation. Currently, we do not perform ECPR for age > 50-60 years if there has been more than 45 min of mechanical resuscitation or life expectancy is less than 6 months (Table 3) . Currently, physicians are encouraged to call the ECMO hotline, with the ultimate decision of whether or not to cannulate the patient left to the discretion of the on-call CT surgeon.
Anticoagulation and cannulation
Anticoagulation is most commonly accomplished using heparin infusion to maintain a partial thromboplastin time (PTT) of 40-50 s for VA ECMO and for VV ECMO utilizing single-lumen, dual-cannula technique. PTT goal of 50-60 s is used for a dual-lumen, single-cannula configuration provided by the Avalon Elite Catheter (Maquet, Rastatt, Germany). We prefer jugular vein-femoral vein configuration for VV ECMO, particularly for trauma patients in which anticoagulation is not without risk. This configuration allows the use of low dose or even no heparin and has been utilized successfully at our institution.
Mobile ECMO
The advent of our ECMO Hotline also allowed our facility to provide ECMO services to the medical community of South Florida, thus firmly establishing our institution as a tertiary referral center for ECMO therapy. Commonly, patients are accepted as ICU to ICU transfers and are evaluated for ECMO on arrival to our institution. Less common, we have sent our mobile ECMO team to local hospitals for evaluation of patients, cannulation, and subsequent transfer.
Outcomes
The implementation of a formal adult ECMO program in June 2016 led to a dramatic increase in utilization. In the first 12 months, we performed over 80 cannulations, more than in the three previous years combined. We improved our survival rates in all categories of ECMO support, including VV, VA, and ECPR. Our VV and VA ECMO survival rates went from 0% in 2014 to being equal to or better than the ELSO international average for both modalities. We believe that this improvement in our outcomes is directly related to the efforts of the MAS-CARE Network embodied by a dedicated multidisciplinary team working relentlessly to standardize protocols, seek opportunity for improvement, ask clinical questions, conduct ground breaking research, and bring a high-quality ECMO program to South Florida.
